212 related articles for article (PubMed ID: 21915630)
1. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
[TBL] [Abstract][Full Text] [Related]
2. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
3. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
4. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.
Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK
Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945
[TBL] [Abstract][Full Text] [Related]
5. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
Choudhuri SK; Chatterjee A
Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
[TBL] [Abstract][Full Text] [Related]
6. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
Ghosh RD; Banerjee K; Das S; Ganguly A; Chakraborty P; Sarkar A; Chatterjee M; Choudhuri SK
Eur J Pharm Sci; 2013 Jul; 49(4):737-47. PubMed ID: 23665413
[TBL] [Abstract][Full Text] [Related]
7. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
Banerjee K; Biswas MK; Choudhuri SK
J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
[TBL] [Abstract][Full Text] [Related]
8. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
[TBL] [Abstract][Full Text] [Related]
9. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK
Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020
[TBL] [Abstract][Full Text] [Related]
10. Menadione reduced doxorubicin resistance in Ehrlich ascites carcinoma cells in vitro.
Xu CJ; Zhang Y; Wang J; Zhang TM
Zhongguo Yao Li Xue Bao; 1998 May; 19(3):273-6. PubMed ID: 10375743
[TBL] [Abstract][Full Text] [Related]
11. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
[TBL] [Abstract][Full Text] [Related]
13. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
Basu S; Ganguly A; Chakraborty P; Sen R; Banerjee K; Chatterjee M; Efferth T; Choudhuri SK
Biochimie; 2012 Jan; 94(1):166-83. PubMed ID: 22037022
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
Akan I; Akan S; Akca H; Savas B; Ozben T
Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
[TBL] [Abstract][Full Text] [Related]
15. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
Xu HB; Li L; Fu J; Mao XP; Xu LZ
Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
[TBL] [Abstract][Full Text] [Related]
16. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR
Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243
[TBL] [Abstract][Full Text] [Related]
17. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
18. Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.
Deng J; Coy D; Zhang W; Sunkara M; Morris AJ; Wang C; Chaiswing L; St Clair D; Vore M; Jungsuwadee P
J Pharmacol Exp Ther; 2015 Nov; 355(2):272-9. PubMed ID: 26354996
[TBL] [Abstract][Full Text] [Related]
19. Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate.
Ganguly A; Basu S; Chakraborty P; Chatterjee S; Sarkar A; Chatterjee M; Choudhuri SK
PLoS One; 2010 Jun; 5(6):e11253. PubMed ID: 20582168
[TBL] [Abstract][Full Text] [Related]
20. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
